Dr. Norma Vergne - Santiago, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 100 Calle Comercio Ste 5, Juana Diaz, PR 00795 Phone: 787-260-0480 Fax: 787-260-0480 |
Dr. Guireida Rivera Colon, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 24 Calle Dr Veve, Juana Diaz, PR 00795 Phone: 787-837-5952 Fax: 787-837-5952 |
News Archive
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration (FDA) has tentatively scheduled a Division of Metabolic and Endocrine Drug Products Advisory Committee meeting on December 7, 2010 to review the Company's New Drug Application (NDA) for Contrave® (naltrexone sustained release (SR)/bupropion SR) for the treatment of obesity.
Consumption of dietary fiber can prevent obesity, metabolic syndrome and adverse changes in the intestine by promoting growth of "good" bacteria in the colon, according to a study led by Georgia State University.
After peaking in 2007, AIDS mortality in South Africa has decreased with the widespread introduction of effective antiretroviral therapy, according to updated estimates published in AIDS, official journal of the International AIDS Society. AIDS is published by Wolters Kluwer.
A newly completed New York University study of public reaction to the 9/11 attacks concludes that people in positions of power, from government officials to managers working on Wall Street to military personnel, tended to interpret the events in more abstract terms and with more certainty and positivity than ordinary individuals.
› Verified 4 days ago